Ryan Specialty Holdings, Inc. (NYSE:RYAN) Given Average Recommendation of “Hold” by Analysts

Ryan Specialty Holdings, Inc. (NYSE:RYAN) has been assigned a consensus recommendation of “Hold” from the eleven brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $70.33.

Several analysts have recently weighed in on the stock. BMO Capital Markets upgraded shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and lifted their target price for the company from $65.00 to $75.00 in a research report on Tuesday, September 24th. JPMorgan Chase & Co. upped their price objective on Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a research note on Friday, August 2nd. Wells Fargo & Company raised their target price on Ryan Specialty from $63.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 10th. Bank of America upped their price target on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research report on Thursday, October 10th. Finally, UBS Group lifted their price objective on Ryan Specialty from $67.00 to $76.00 and gave the company a “buy” rating in a report on Tuesday, August 13th.

Ryan Specialty Trading Up 1.3 %

Ryan Specialty stock opened at $66.71 on Monday. Ryan Specialty has a 12 month low of $41.49 and a 12 month high of $73.10. The stock has a market cap of $17.44 billion, a price-to-earnings ratio of 86.64, a price-to-earnings-growth ratio of 1.49 and a beta of 0.62. The business has a 50 day moving average price of $67.04 and a two-hundred day moving average price of $60.49. The company has a quick ratio of 1.09, a current ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. The firm had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty’s quarterly revenue was up 20.5% compared to the same quarter last year. During the same period last year, the business earned $0.32 earnings per share. As a group, equities analysts forecast that Ryan Specialty will post 1.81 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.44 annualized dividend and a yield of 0.66%. Ryan Specialty’s dividend payout ratio (DPR) is 57.14%.

Insider Buying and Selling at Ryan Specialty

In related news, President Timothy William Turner sold 2,000,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $62.45, for a total value of $124,900,000.00. Following the completion of the transaction, the president now owns 8,095 shares in the company, valued at $505,532.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, Director Nicholas Dominic Cortezi sold 1,500 shares of Ryan Specialty stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $65.02, for a total transaction of $97,530.00. Following the completion of the sale, the director now owns 25,123 shares in the company, valued at $1,633,497.46. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, President Timothy William Turner sold 2,000,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $62.45, for a total transaction of $124,900,000.00. Following the sale, the president now directly owns 8,095 shares of the company’s stock, valued at approximately $505,532.75. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,107,136 shares of company stock worth $131,860,032. 11.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ryan Specialty

Several hedge funds have recently added to or reduced their stakes in the stock. Maryland State Retirement & Pension System raised its position in shares of Ryan Specialty by 19.4% in the 1st quarter. Maryland State Retirement & Pension System now owns 7,556 shares of the company’s stock valued at $381,000 after acquiring an additional 1,227 shares during the period. Diversify Advisory Services LLC acquired a new stake in Ryan Specialty in the first quarter worth $303,000. Janney Montgomery Scott LLC grew its holdings in shares of Ryan Specialty by 57.3% in the 1st quarter. Janney Montgomery Scott LLC now owns 12,136 shares of the company’s stock valued at $674,000 after buying an additional 4,421 shares during the period. Capstone Investment Advisors LLC acquired a new position in shares of Ryan Specialty in the 1st quarter valued at $727,000. Finally, FORA Capital LLC increased its position in shares of Ryan Specialty by 20.0% in the 1st quarter. FORA Capital LLC now owns 14,343 shares of the company’s stock valued at $796,000 after buying an additional 2,392 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.